Mantle Cell Lymphoma: Interactive Case Specific Guidance in Treatment Selection and Duration on Treatment Optimization From EU Experts

This program aims to improve knowledge and competence in the personalization of the care of patients with MCL by focusing on strategies to optimize treatment and proactively manage treatment-related adverse events to extend treatment duration and achieve maximal outcomes through the use of unique Interactive Decision Support Tools and an expert-authored text module with accompanying slides.

Share

Program Content

Activities

EU Focused MCL IDST
Interactive Decision Support Tool: EU-Focused MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: April 09, 2025

Expires: October 08, 2025

Activities

Tx Selection and Optimization in MCL
Treatment Selection and Optimization in MCL From a European Union Perspective
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2025

Expires: October 14, 2025

Activities

Tx Selection and Optimization in MCL
Treatment Selection and Optimization in MCL From a European Union Perspective
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2025

Expires: October 14, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca